Women’s Cancer Screening Test (Trucheck FemmeSafe) in Leicester

The Health Suite Leicester offers a comprehensive range of women’s health services, including advanced cancer screening options in Leicester.  At The Health Suite Leicester, the Trucheck FemmeSafe is a blood-based multi-cancer screening test designed for asymptomatic women, typically over 40, with no prior history or current suspicion of cancer. This innovative test detects circulating tumour cells to identify early signs of breast, ovarian, cervical, and uterine cancers. For more information on women’s health services and available screenings.

The Trucheck FemmeSafe is an advanced, non-invasive blood test designed specifically for women to screen for multiple types of cancers, including breast, ovarian, cervical, and uterine cancers. By analysing circulating tumour cells (CTCs) and specific biomarkers in the bloodstream, the Trucheck FemmeSafe Women’s Cancer Screening Test can detect cancer at its earliest stages, often before symptoms become apparent. This early detection is crucial, as it significantly improves the chances of successful treatment and better health outcomes. Recommended for women over 30 or those with a family history of cancer, the test is simple, safe, and convenient, requiring only a blood sample. While Trucheck FemmeSafe is highly sensitive, any positive result would need to be followed up with additional diagnostic tests to confirm the presence of cancer. It offers a proactive approach to women’s health, giving individuals the ability to monitor their risk and take timely action if needed.

Women’s Cancer Screening Test is a revolutionary multicancer cancer screening test based on a simple fasting blood draw. It screens for early detection of common female cancers such as breast cancer, cervical cancer, ovarian cancer, uterine cancer or endometrial cancer.

• Cervical Cancer: It is the 14th most common cancer in the UK in females, with 3200 new cases every year. 1 in 142 females will get it in their lifetime. [1] Risk factors include smoking, oral contraceptive pill use, HPV infection, and multiple sexual partners. It is more commonly diagnosed in women under the age of 45. [1]
• Endometrial Cancer: Is the most common gynaecological cancer in the UK, with 1 in 36 females affected over their lifetime. Each year, there are approximately 9700 new cases. Rates of this cancer have been increasing and more commonly affect females aged over 50 years, highest rates in those aged 75-79 [2]
• Ovarian Cancer: Ovarian cancer is the 6th most common cancer in females, with approximately 7500 new cases every year. It is more common in older females and will affect 1 in 50 females over their lifetime. [3] Survival rates with treatment have doubled in the last 50 years. [3]
• Breast Cancer: 1 in 7 women will develop breast cancer in their lifetime. With over 55,000 new cases every year. Early diagnosis when breast cancer is localised can significantly improve the chances of survival. [4] Risk factors for breast cancer include HRT, oral contraceptive pills, being overweight or obese, excessive alcohol and not breastfeeding. [4] FemmeSafe can detect the top 4 cancers for women at early stages: Cervical, Endometrial, Ovarian & Breast

Early detection of cancers in women is crucial because it significantly increases the chances of successful treatment and survival. Many cancers, such as breast, cervical, ovarian, and uterine cancer, may not show symptoms in their early stages, which is why regular screenings and early tests are essential. Detecting cancer before it spreads allows for less aggressive treatments, fewer side effects, and a higher likelihood of complete recovery. Furthermore, early detection often leads to less invasive surgeries, reduced treatment costs, and a better quality of life. By prioritising early screenings, women can take control of their health, ensuring that any potential risks are identified and managed in time for the best possible outcome.